^99mTc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe

• Hauptverfasser: Guillermina Ferro-Flores (VerfasserIn), Blanca Ocampo-García (VerfasserIn), Pedro Cruz-Nova (VerfasserIn), Myrna Luna-Gutiérrez (VerfasserIn), Gerardo Bravo-Villegas (VerfasserIn), Erika Azorín-Vega (VerfasserIn), Nallely Jiménez-Mancilla (VerfasserIn), Emiliano Michel-Sánchez (VerfasserIn), Osvaldo García-Pérez (VerfasserIn), Nancy Lara-Almazán (VerfasserIn), Clara Santos-Cuevas (VerfasserIn)
• Format: Buch
• Veröffentlicht: MDPI AG, 2023-11-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Recent cancer therapies have focused on reducing immune suppression in the tumor microenvironment to prevent cancer progression and metastasis. PD-1 is a checkpoint protein that stops the immune response and is expressed on immune T cells. Cancer cells express a PD-1 ligand (PD-L1) to bind to the T-...